Delving Into Participation Trends of Scleroderma Clinical Trials

Typically, specific demographic subsets tend to exhibit greater engagement in medical research. Nonetheless, there is insufficient research elucidating the trial characteristics influencing the participation of these particular demographics.

The study will analyze data from diverse demographic viewpoints to uncover recurring trends that could provide valuable insights for future patients with scleroderma.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Scleroderma Connective Tissue Diseases Scleroderma, Diffuse Scleroderma, Systemic Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Power Life Sciences

San Francisco, California, 94107, United States

Location contact

Michael B Gill

CONTACT

https://www.withpower.com/[email protected]

415-900-4227

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient has been diagnosed with scleroderma
Patient has self-identified as planning to enroll in an observational clinical trial
Patient is a minimum of 18 years or older

Exclusion criteria

Patient is pregnant
Inability to perform regular electronic reporting
Patient does not understand, sign, and return consent form

Treatment and study plan

Primary outcomes

Rate of patients in clinical research for scleroderma

Time frame: 3 months
Number of scleroderma study participants who stay committed until clinical study wraps up

Time frame: 12 months

Study contacts

Contact information is provided by the study sponsor or research team.

Michael B Gill

CONTACT

[email protected]

4159004227

Sponsors and collaborators

Lead sponsor

Power Life Sciences Inc.

Industry

Registry information

Official study title

Deciphering Patient Participation: Insights From Observational Data in Scleroderma Clinical Trials

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2027
First posted: Feb 20, 2024
Registry last updated: Feb 28, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting